Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04503044 · ClinicalTrials.gov registry record
ILAs in CT Lung Cancer Screening Population
A clinical trial, sponsored by Lahey Clinic.
- Completed
- Registry status
- 1,703
- Enrollment target
NCT04503044 is a clinical trial that has completed, run by Lahey Clinic. The registered enrollment target is 1,703 participants.
The verdict
NCT04503044 has completed, sponsored by Lahey Clinic.
- COMPLETED
- Registry status
- 1,703 participants
- Enrollment target
Study Summary
Interstitial Lung Abnormalities (ILA) have been previously defined as nondependent changes affecting more than 5% of any lung zone on computed tomography (CT) scans of the lung. Several studies suggest that the prevalence of ILA in participants in non-pulmonary research studies ranges anywhere from 7-9%. Work over the last decade has shown that, despite previous characterization as an asymptomatic research finding, ILA has significant clinical and biological consequences. These include reduced exercise capacity, functional limitations, decreased lung volumes, increased mortality, and in some cases histopathology similar to Idiopathic Pulmonary Fibrosis (IPF). ILA have been detected in lung cancer screening cohorts, where the prevalence of ILA is estimated to be between (10%-20%) to those noted in other research cohorts. Given that a significant proportion of those will have progression, CT lung cancer screening (CTLS) cohorts represent an ideal catchment population for future research and clinical trials. Lahey Hospital and Medical Center was one of the earliest clinical centers to develop a CTLS program in the country. Investigators propose to qualitatively characterize ILA in a large clinical CTLS population.
Interventions
- OTHER Retrospective observational study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,703 participants |
| Start Date | 2021-01-30 |
| Est. Completion | 2021-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04503044
The ClinicalTrials.gov registry entry for NCT04503044 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,703 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lahey Clinic, which has 43 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Retrospective observational study is the first listed.
NCT04503044 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04503044 about?
NCT04503044 is a clinical study titled "ILAs in CT Lung Cancer Screening Population". Interstitial Lung Abnormalities (ILA) have been previously defined as nondependent changes affecting more than 5% of any lung zone on computed tomography (CT) scans of the lung. Several studies suggest that the prevalence of ILA in participants in non-pulmonary research studies ranges anywhere from ...
What is the current status of trial NCT04503044?
This trial is currently completed. The enrollment target is 1,703 participants. The study started on 2021-01-30. Estimated completion is 2021-06-30.
What interventions are being tested in trial NCT04503044?
The interventions under investigation include: Retrospective observational study (OTHER).
Who is sponsoring clinical trial NCT04503044?
This trial is sponsored by Lahey Clinic, which has 43 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.